Molecular Psychiatry
This journal publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatment, with emphasis on studies at the interface of pre-clinical and clinical research.
New tricks from old drugs: repurposing the 80s
A paper in Molecular Psychiatry describes a new cell biological mechanism regulated by antidepressants, showing how a single dose of a drug fluvoxamine may open up the brain for drug delivery. Can this finding signal the beginning of a brand new career for the 30+ year-old drugs?